Newton, MA, United States of America

Joon Jung

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 11.1

ph-index = 4

Forward Citations = 77(Granted Patents)


Location History:

  • Natick, MA (US) (2015)
  • Newton, MA (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: The Innovator Joon Jung: Pioneering CNS Treatments

Introduction

Joon Jung, based in Newton, MA, is a notable inventor with an impressive portfolio, holding 22 patents to his name. His work primarily focuses on advancements in pharmaceutical formulations, particularly in the field of central nervous system (CNS) diseases.

Latest Patents

One of his latest contributions is centered around SGC stimulators, which are pivotal for treating various medical conditions. The patent disclosure reveals stimulators of soluble guanylate cyclase (sGC) that enhance the concentration of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP). This innovative approach aims to regulate the NO pathway effectively. Additionally, Jung's research emphasizes the application of sGC stimulators in treating CNS diseases, further highlighting their potential in improving patient outcomes through increased sGC stimulation and relevant biochemical activity.

Career Highlights

Joon Jung has made significant strides in his career, having worked with prestigious organizations. He was a part of Merck Sharp & Dohme Corporation, where he contributed to pharmaceutical advancements, as well as Cyclerion Therapeutics, Inc., a company that focuses on innovative treatments for serious diseases. His career reflects a deep commitment to research and innovation in pharmaceuticals.

Collaborations

Throughout his career, Jung has collaborated with esteemed colleagues such as Rajesh R. Iyengar and Thomas Wai-Ho Lee. These professional relationships have fostered knowledge sharing and have likely contributed to his inventive successes in developing efficacious treatments.

Conclusion

Joon Jung exemplifies the spirit of innovation in the pharmaceutical industry through his extensive work on patents aimed at addressing essential health challenges. His ongoing dedication to research and collaboration continues to pave the way for breakthroughs in treating CNS diseases, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…